(Q40711468)

23 September 2017

title

High dose methotrexate followed by citrovorum factor reversal in patients with advanced cancer (English)

1 reference

10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1177::AID-CNCR2820430403%3E3.0.CO;2-R

9 March 2023

1 reference

1 reference

1 reference

10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1177::AID-CNCR2820430403%3E3.0.CO;2-R

9 March 2023

author name string

E. P. Ambinder

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A312690

9 March 2023

M. Perloff

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A312690

9 March 2023

T. Ohnuma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A312690

9 March 2023

H. F. Biller

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A312690

9 March 2023

J. F. Holland

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A312690

9 March 2023

language of work or name

English

0 references

publication date

1 April 1979

1 reference

full work available at URL

23 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197904)43:4%3C1177::AID-CNCR2820430403%3E3.0.CO;2-R

1 reference

10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1177::AID-CNCR2820430403%3E3.0.CO;2-R

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197904)43:4%3C1177::AID-CNCR2820430403%3E3.0.CO;2-R

9 March 2023

1 reference

10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1177::AID-CNCR2820430403%3E3.0.CO;2-R

9 March 2023

1 reference

23 September 2017

volume

43

1 reference

23 September 2017

issue

4

1 reference

23 September 2017

page(s)

1177-1182

1 reference

23 September 2017

1

30

1782

Capizzi

1970

1 reference

10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1177::AID-CNCR2820430403%3E3.0.CO;2-R

Continuous infusion of methotrexate in children with acute leukemia

9 March 2023

3

1 reference

10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1177::AID-CNCR2820430403%3E3.0.CO;2-R

Methotrexate and citrovorum factor rescue in the management of childhood lymphosarcoma and reticulum cell sarcoma (non-Hodgkin's lymphomas): parolonged unmaintained remissions

9 March 2023

4

1 reference

10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1177::AID-CNCR2820430403%3E3.0.CO;2-R

New approaches to cancer chemotherapy with methotrexate

9 March 2023

7

1 reference

10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1177::AID-CNCR2820430403%3E3.0.CO;2-R

9 March 2023

Molecular Pharmacology

8

10

257

Goldman

1974

1 reference

10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1177::AID-CNCR2820430403%3E3.0.CO;2-R

9 March 2023

9

32

1506

Hryniuk

1972

1 reference

10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1177::AID-CNCR2820430403%3E3.0.CO;2-R

Recent advances in the chemotherapy of metastatic osteogenic sarcoma

9 March 2023

10

1 reference

10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1177::AID-CNCR2820430403%3E3.0.CO;2-R

Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma

9 March 2023

11

1 reference

10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1177::AID-CNCR2820430403%3E3.0.CO;2-R

9 March 2023

13

33

1729

Levitt

1973

1 reference

10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1177::AID-CNCR2820430403%3E3.0.CO;2-R

9 March 2023

14

28

1088

Mitchell

1968

1 reference

10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197904)43:4%3C1177::AID-CNCR2820430403%3E3.0.CO;2-R

9 March 2023

Identifiers

10.1002/1097-0142(197904)43:4<1177::AID-CNCR2820430403>3.0.CO;2-R

1 reference

23 September 2017

1 reference